SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001082554-24-000019
Filing Date
2024-04-29
Accepted
2024-04-29 07:02:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A uthr2024-defa14a.htm DEFA14A 10775
2 GRAPHIC a04_426841-3xphotoxunitedt.jpg GRAPHIC 26694
3 GRAPHIC defa1.jpg GRAPHIC 1066378
4 GRAPHIC defa2.jpg GRAPHIC 890500
  Complete submission text file 0001082554-24-000019.txt   2742995
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26301 | Film No.: 24886550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)